Baxter International to Host 2016 Investor Conference

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX) announced today that it will host an investor conference on Monday, May 9, 2016 in New York City at the Pierre Hotel. The investor conference will feature an innovation hall displaying product and therapy advancements from Baxter’s pipeline beginning at 11:00 a.m. EDT. Presentations by members of the Baxter management team will commence at 1:00 p.m. EDT.

To register for the conference, please visit www.baxter.com. Additional details are available on the company’s website.

The meeting and accompanying slides will be webcast live by Nasdaq OMX and will be accessible from Baxter’s corporate website at www.baxter.com. The meeting will be recorded by Baxter as copyrighted material and cannot be recorded or rebroadcast without Baxter’s permission.

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160405006739/en/

Baxter International Inc.
Media Contact
Deborah Spak, (224) 948-2349
or
Investor Contact
Clare Trachtman, (224) 948-3085

Source: Baxter International Inc.

You May Also Be Interested In

• UPDATE: LifeWallet Announces a Comprehensive Settlement with a Group of Affiliated Property & Casualty Insurers 
• Press Release for Early Warning Report Filed Pursuant to NI 62-103
• Telescope Innovations Presents Results of Second Fiscal Quarter 2024